Yvonne R. Freund - Concepedia

Author

Yvonne R. Freund

University of California, San Francisco ORCID

Also Known As

Y Freund, Y R Freund, Y. Freund, Y. R. Freund, Y.R. Freund, Yvonne Freund, Yvonne R Freund, Yvonne R. Freund

Publications

3.1K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco SRI International Swiss Tropical and Public Health Institute Wellcome Centre for Molecular Parasitology University of Glasgow

About

Yvonne R. Freund is an author at University of California, San Francisco specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	26	1.7K
2	Natural Sciences	10	10	610
3	Biochemistry	10	10	609
4	Health Sciences	2	2	209
5	Social Sciences	1	1	78

Yvonne R. Freund

Publications

Citations

H-Index

Page 1

	Year	Citations
SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis Robert T. Jacobs, Bakela Nare, Stephen A. Wring, PLoS neglected tropical diseases	2011	294
Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis Tsutomu Akama, Stephen J. Baker, Yongkang Zhang, Bioorganic & Medicinal Chemistry Letters InflammationMedicinal ChemistryAnti-inflammatoryAtopic DermatitisMedicine	2009	207
Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria Vincent Hernandez, Thibaut Crépin, Andrés Palencia, Antimicrobial Agents and Chemotherapy Available AntibioticsMicrobial PathogensLead AnalogueBoron-based AntibacterialsAntimicrobial Chemotherapy	2013	195
A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue Ebere Sonoiki, Caroline L. Ng, Denghui Guo, Nature Communications	2017	137
Clinical and veterinary trypanocidal benzoxaboroles target CPSF3 Richard J. Wall, Eva Rico, Iva Lukač, Proceedings of the National Academy of Sciences	2018	124
Boron‐based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center Yvonne R. Freund, Tsutomu Akama, M.R. Alley, FEBS Letters Pharmaceutical SciencePhosphodiesterase 4PharmacotherapyChemical BiologyBoron-based Molecules	2012	107
Immune response gene expression increases in the aging murine hippocampus Akira Terao, Anjali Apte-Deshpande, Linda Dousman, Journal of Neuroimmunology Alzheimer's DiseaseAgingMedicineImmunologyCellular Senescence	2002	107
Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis Bakela Nare, Stephen A. Wring, Cyrus J. Bacchi, Antimicrobial Agents and Chemotherapy	2010	102
Discovery of Novel Benzoxaborole-Based Potent Antitrypanosomal Agents Dazhong Ding, Yaxue Zhao, Qingqing Meng, ACS Medicinal Chemistry Letters Medicinal ChemistryAntimicrobial Drug DiscoveryCentral Linkage GroupsBiochemistryAntiparasitic Agent	2010	101
Benzoxaboroles: A New Class of Potential Drugs for Human African Trypanosomiasis Robert T. Jacobs, Jacob J. Plattner, Bakela Nare, Future Medicinal Chemistry Lead CompoundsBioorganic ChemistryAntiparasitic AgentMalariaPathology	2011	87

Page 1